Literature DB >> 12871988

Immunohistochemical comparison of anti-prion protein (PrP) antibodies in the CNS of mice infected with scrapie.

Wing Gee Liu1, Debbie A Brown, Janet R Fraser.   

Abstract

One of the pathological changes characteristic of the transmissible spongiform encephalopathies (TSEs) is the accumulation of disease-specific PrP (PrP(sc)). Immunolabeling of PrP(sc) was compared using a panel of monoclonal and polyclonal antibodies. To determine the effects of tissue fixation on immunostaining, we performed a supplementary investigation reviewing the fixatives formol saline and periodate-lysine-paraformaldehyde (PLP). The main target sites of the antibodies were similar. However the monoclonal antibodies (MAbs) 6H4, 7A12 and 8H4 revealed targeted PrP(sc) labeling with no background labeling. Although 7A12 and 8H4 did not detect early PrP deposition, we propose that during the later stages of disease 7A12 and 8H4 can be used with equal effectiveness in place of 6H4. Tissues taken during the early stages of disease that had been fixed in PLP displayed more PrP immunolabeling than tissues that had undergone formol fixation. PLP fixation on 6H4-immunostained tissue revealed interweaving granular linear PrP deposits in the hippocampus. This labeling was not observed in tissue that had undergone formol fixation, suggesting that PLP fixation might enhance the sensitivity of the immunohistochemical (IHC) detection of PrP. In the two scrapie mouse models studied here, PLP fixation and immunolabeling with the anti-PrP antibody 6H4 gave superior results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871988     DOI: 10.1177/002215540305100810

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  6 in total

1.  Protective role of interferon regulatory factor 3-mediated signaling against prion infection.

Authors:  Daisuke Ishibashi; Ryuichiro Atarashi; Takayuki Fuse; Takehiro Nakagaki; Naohiro Yamaguchi; Katsuya Satoh; Kenya Honda; Noriyuki Nishida
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Lesion profiling and subcellular prion localization of cervid chronic wasting disease in domestic cats.

Authors:  D M Seelig; A V Nalls; M Flasik; V Frank; S Eaton; C K Mathiason; E A Hoover
Journal:  Vet Pathol       Date:  2014-02-27       Impact factor: 2.221

3.  Chronic wasting disease prion trafficking via the autonomic nervous system.

Authors:  Davis M Seelig; Gary L Mason; Glenn C Telling; Edward A Hoover
Journal:  Am J Pathol       Date:  2011-07-21       Impact factor: 4.307

4.  Mucosal transmission and pathogenesis of chronic wasting disease in ferrets.

Authors:  Matthew R Perrott; Christina J Sigurdson; Gary L Mason; Edward A Hoover
Journal:  J Gen Virol       Date:  2012-10-24       Impact factor: 3.891

5.  Intraperitoneal Infection of Wild-Type Mice with Synthetically Generated Mammalian Prion.

Authors:  Xinhe Wang; Gillian McGovern; Yi Zhang; Fei Wang; Liang Zha; Martin Jeffrey; Jiyan Ma
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

6.  Microdissection: a method developed to investigate mechanisms involved in transmissible spongiform encephalopathy pathogenesis.

Authors:  Janice B Barr; Robert A Somerville; Yuen-Li Chung; Janet R Fraser
Journal:  BMC Infect Dis       Date:  2004-03-03       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.